Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance

Humana IncTrade
iShares iBoxx $ Inv Grade Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Humana Inc trades at $438.01 (market cap $46.49B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.24 (market cap $28.50B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.91% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares iBoxx $ Inv Grade Corporate Bond ETF for 125 Days on average.

HUMLQD
Market Cap
$46.49B$28.50B
Volume
2,567,70437,320,110
Sector
HealthFixed Income
52-Week High
$409.85$112.91
52-Week Low
$163.67$101.83
Typical Hold Time
53 Days125 Days
Enterprise Value
$53.84B—
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.

The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.

iShares iBoxx $ Inv Grade Corporate Bond ETF

LQD, the iShares iBoxx $ Investment Grade Corporate Bond ETF, trades at $102.295, up slightly by 0.17% on the day. The technical outlook is bearish, with moving averages signaling selling pressure, while oscillators are neutral. Recent news highlights a significant increase in short interest and a challenging environment for bonds due to rising yields. The fund maintains a 4.8% yield, with recent dividend payments, but faces headwinds from higher interest rates impacting corporate borrowing costs.

The outlook for LQD is cautious amid a rising rate environment, which pressures bond prices. Investment opportunities lie in its high-quality corporate bond portfolio and steady yield, but risks include further yield increases and economic slowdowns affecting credit quality. Investors should weigh the fund's income generation against interest rate sensitivity and market volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About iShares iBoxx $ Inv Grade Corporate Bond ETF

The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.

Read more on LQD →